The Research and Development Department includes three clusters of disease expert teams: NTD: Mycetoma and Leishmaniasis; NTD: Chagas, Filarial, and HAT; and Viral Diseases. These teams drive therapeutic innovation from the lab bench to the patientbedside, advancing DNDi’s portfolio of treatment candidates from the outset (with the design of target product profiles) to theend point (enabling patients’ access to new treatments). DNDi established its Latin American office in Rio de Janeiro in 200…